BIO-PATH HOLDINGS INC

For the period ended Dec 31, 2023. Filed Mar 7, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 7, 2024

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except par value)


· As of December 31, · As of December 31,
· · 2023 · · 2022
Assets · ·
· ·
Current assets · ·
Cash	$1,052	$10,384
Prepaid drug product	632	3,587
Other current assets	1,358	1,644
Total current assets	3,042	15,615

Fixed assets
Furniture, fixtures & equipment	1,120	1,120
Less accumulated depreciation	(1,044)	(962)
	76	158

Right of use operating assets	102	198

Total Assets	$3,220	$15,971
Liabilities & Shareholders' Equity
Current liabilities
Accounts payable	$457	$667
Accrued expenses	1,346	909
Current portion of lease liabilities	103	108
Total current liabilities	1,906	1,684

Warrant liability	863	—

Noncurrent lease liabilities	10	113

Total Liabilities	2,779	1,797

Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	—	—
Common stock, $.001 par value; 200,000 shares authorized; 618 and 398 shares issued and outstanding, respectively	1	1
Additional paid in capital	108,047	105,702
Accumulated deficit	(107,607)	(91,529)
Total shareholders' equity	441	14,174
Total Liabilities & Shareholders' Equity	$3,220	$15,971

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.